• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$0.08 $0.00 (0.25%)

Quote as of

ADVANCED CELL TECH INC

NASDAQOTCBB:ACTC.OB

Advanced Cell Technology to Present at World Stem Cells & Regenerative Medicine Congress in London

Advanced Cell Technology to Present at World Stem Cells & Regenerative Medicine Congress in London

Biotech Companies Look to Benefit From Transformed Patent System

Advanced Cell Technology Announces 2012 First Quarter Results

Advanced Cell Technology Announces 2012 First Quarter Results

Advanced Cell Technology to Host Conference Call to Discuss 2012 First Quarter Results and Provide Corporate Update on Wednesday, May 9th

Advanced Cell Technology Announces Webcast of Corporate Presentation at Annual Shareholders’ Meeting Today

Advanced Cell Technology Announces Webcast of Corporate Presentation at Annual Shareholders’ Meeting Today

ACT Announces Data and Safety Monitoring Board (DSMB) Approval to Increase RPE Dosage for Stargardt’s Disease Patients in U.S. Trial

Advanced Cell Technology announces third dry AMD patient treated in trial

ACT Announces Third Dry AMD Patient Treated in Clinical Trial

Global Technology to host a summit

ACT Announces Second Patient with Dry AMD Treated in U.S. Clinical Trial with RPE Cells Derived from Embryonic Stem Cells

Troublesome March for Stem Cell Companies

Advanced Cell Technology to Webcast 2012 Annual Shareholders’ Meeting on April 26th

Advanced Cell Technology to Webcast 2012 Annual Shareholders’ Meeting on April 26th

StockBrainiac.com Active Watch List: - Cannabis Science Inc. (OTCBB: CBIS), Advanced Cell Technology Inc. (OTCBB: ACTC), Titan Pharmaceuticals Inc. (OTCBB: TTNP), Silver Falcon Mining Inc. (OTCBB: SFMI)

ACT Appoints Michael Heffernan to Board of Directors

Advanced Cell Technology announces approval of additional site for trial

ACT Announces Approval of Bascom Palmer Eye Institute as Additional Site for Stem Cell Clinical Trial for dry Age-Related Macular Degeneration

Advanced Cell Technology and PharmAthene Poised to Benefit From Positive Legislation

Advanced Cell Technology and PharmAthene Poised to Benefit From Positive Legislation

Advanced Cell Technology announces filing of definitive proxy

ACT Announces Filing of Definitive Proxy

Advanced Cell Technology to Present at the 24th Annual ROTH Conference

StockMister.com Volume Watch List: Legend Oil & Gas (LOGL), Lpath (LPTN), North Springs Resources (NSRS), Rentech (RTK), Advanced Cell Tech (ACTC)

StockMister.com Volume Watch List: Legend Oil & Gas (LOGL), Lpath (LPTN), North Springs Resources (NSRS), Rentech (RTK), Advanced Cell Tech (ACTC).

Clubpennystocks Volume WatchList: BFLX (Bioflamex Corp), KMIIV (Kinder Morgan), TFER (Titan Iron Ore), CBIS (Cannabis Science), LOGL (Legend Oil/Gas), ACTC (Advanced Cell Tech), NOKBF Nokia Corp

Clubpennystocks Volume WatchList: BFLX (Bioflamex Corp), TFER (Titan Iron Ore), CBIS (Cannabis Science), MSTG (Mustang Alliances), KMIIV (Kinder Morgan), LPTN (Lpath), ACTC (Advanced Cell Tech)

StockMister.com Volume Watch List: Legend Oil & Gas (LOGL), Titan Iron Ore (TFER), North Springs Resources (NSRS), Rentech (RTK), Advanced Cell Tech (ACTC)

Clubpennystocks Volume WatchList: TFER (Titan Iron Ore), CBIS (Cannabis Science), IYRS (iTrackr Systems), MSTG (Mustang Alliances), ACTC (Advanced Cell Tech), KMIIV (Kinder Morgan)

StockMister.com Volume Watch List: Legend Oil & Gas (LOGL), Chimera Investment Corp (CIM), Immunocellular Therapeutics (IMUC), Rentech (RTK), Advanced Cell Tech (ACTC)

New Stem Cell Research Shows Promising Results -- Advanced Cell Tech and NeoStem Poised to Benefit

New Stem Cell Research Shows Promising Results -- Advanced Cell Tech and NeoStem Poised to Benefit

Advanced Cell Technology Announces 2011 Financial Results

Advanced Cell Technology To Announce 2011 Fourth Quarter and Year-End Results on March 1st

Advanced Cell Technology Announces Approval of Wills Eye Institute as Additional Site for Stem Cell Clinical Trial for Stargardt’s Disease

Advanced Cell Technology announces approval of Wills Eye stem cell site

Advanced Cell Technology Announces Approval of Wills Eye Institute as Additional Site for Stem Cell Clinical Trial for Stargardt’s Disease

Favorable News From Advanced Cell Technology and StemCells Inc Boosts Optimism in Regenerative Medicine Industry

See More Articles...